stockrowICU Medical, Inc.
ICUI Healthcare Medical Instruments & Supplies
ICU Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, down 6.33% from fiscal 2024.
- Revenue
- +4.37%
- EPS
- +864.3%
- Free cash flow
- +292.2%
- Total debt
- −12.3%
Quarter to September 2026, against a year earlier
Follow ICUI
Alert me
ICU Medical, Inc. (ICUI) EBITDA
ICU Medical, Inc.'s EBITDA for fiscal 2025 was $249.7M, down 7.25% from $269.3M in fiscal 2024. Over the twelve months to 30 September 2026 it was $314.2M. Over the past ten years it has ranged from $53.4M (fiscal 2017) to $269.3M (fiscal 2024); the current reading is higher than 82% of that period. ICU Medical, Inc. ranks 18th of 47 Medical Instruments & Supplies companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $249.7M | (7.25%) |
| FY2024 | $269.3M | 4.21% |
| FY2023 | $258.4M | 14.47% |
| FY2022 | $225.7M | 5.57% |
| FY2021 | $213.8M | 16.02% |
| FY2020 | $184.3M | (0.21%) |
| FY2019 | $184.7M | 76.18% |
| FY2018 | $104.8M | 96.22% |
| FY2017 | $53.4M | (48.30%) |
| FY2016 | $103.3M | 17.03% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $102.7M | 14.74% |
| Jun 2026 | $89.5M | 39.08% |
| Mar 2026 | $64.4M | 11.91% |
| Dec 2025 | $57.5M | (13.03%) |
| 43 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| NVST Envista Holdings Corporation compare | $428.9M |
| MMSI Merit Medical Systems, Inc. compare | $359.6M |
| STVN Stevanato Group S.p.A. compare | $351.1M |
| ICUI ICU Medical, Inc. | $314.2M |
| TFX Teleflex Incorporated compare | $256.2M |
| WRBY Warby Parker Inc. compare | $59.0M |
| ATRC AtriCure, Inc. compare | $34.2M |
| MMED MiniMed Group, Inc. compare | −$8.0M |
| PLSE Pulse Biosciences, Inc compare | −$82.0M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on ICUI
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement